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Background/aim: To investigate the efficacy of diffusion-weighted magnetic resonance imaging (DWI) in the diagnosis and staging of
fibrosis induced by experimental bile duct ligation (BDL).
Materials and methods: Twenty-four rats were divided randomly into four groups: control, BDL - 3 days, BDL - 2 weeks, and BDL - 4
weeks. DWI was performed with b-values of 100 and 500 on the rats from control group at day zero, on the rats from the BDL - 3 days
group at the end of day 3, on the rats from the BDL - 2 weeks group at the end of day 14, and on the rats from the BDL - 4 weeks at the
end of day 28.
Results: When fibrosis scores generated in all groups were evaluated together, a strong negative correlation was detected between
fibrosis scores and apparent diffusion coefficient (ADC) values measured using b 100 and b 500. ADC values obtained using b 100 were
found to be significantly higher compared to the fibrosis observed in both the BDL - 2 weeks and BDL - 4 weeks groups (P < 0.003 and
P < 0.001, respectively).
Conclusion: We think that DWI may be an alternative to liver biopsy for the diagnosis and staging of hepatic fibrosis with underlying
extrahepatic cholestasis.
Key words: Bile duct ligation, hepatic fibrosis, diffusion-weighted magnetic resonance, experimental extrahepatic cholestasis, rat

1. Introduction
Extrahepatic cholestasis is defined as a blockage of the
passage of bile to the duodenum due to narrowing or
lesions at the level of the common hepatic duct. The
main reasons leading to extrahepatic cholestasis include
common bile duct (CBD) stones, cholangiocarcinoma,
ampullary carcinoma, pancreatic diseases (pancreatic
head carcinoma, pseudotumoral chronic pancreatitis,
pancreatic head pseudocysts), CBD strictures and
congenital malformations (cysts, Caroli disease), duodenal
diverticula, ascaridiasis, and hemobilia (1). In the case of
bile duct obstruction, increased biliary pressure (30–40
cmH2O) and biliary stasis cause histological changes in the
liver. In acute bile duct obstruction, canalicular cholestasis
and the proliferation of the bile duct cells lead to portal
tract alterations. During the chronic stage, increased
periductal connective tissue and fibrosis are observed (2).
* Correspondence: turankaraca@trakya.edu.tr
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Early diagnosis of the hepatic fibrosis may facilitate
interventions to prevent the progression of the fibrosis
to cirrhosis (3–5). Liver biopsy is still considered the
gold standard for the evaluating fibrosis (6). However,
this invasive method may lead to several conditions
ranging from minor complications that do not require
hospitalization, such as pain and bleeding, to major
complications including death. Additionally, another
consideration that limits liver biopsy is sampling error. As
fibrosis has a heterogeneous distribution and only a small
sample should be removed from the liver tissue, sampling
errors are unavoidable (7,8). Due to these limitations
of liver biopsy, serological tests such as the FibroTest
and noninvasive methods such as elastosonography,
perfusion-weighted magnetic resonance, and magnetic
resonance elastography were developed to diagnose
fibrosis (9).
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Diffusion-weighted magnetic resonance imaging
(DWI) is an imaging technique that uses the diffusion
properties of water molecules to illustrate tissue
contrast. DWI is a technique that is commonly used in
neuroradiology in order to detect intracranial infections,
to characterize brain tumors, and to diagnose ischemia
observed in the cerebrovascular pathologies in an early
stage (10–12). The use of DWI in the differentiation and
detection of malignant and benign lesions in other areas of
the body and in the evaluation of pre- and posttreatment
response in liver tumors is relatively new but quite
promising (13). In addition, DWI was suggested to be
likely to be useful in the diagnosis of hepatic fibrosis. DWI
numerically measures the diffusion of water molecules in
the biological tissues using an apparent diffusion coefficient
(ADC). The ADC that was measured using DWI was used
to characterize diffuse liver diseases, such as focal hepatic
lesions and hepatic fibrosis (14).
Several studies suggested that the molecular diffusion
of the water could be limited in the presence of collagen
fibrils with lobular structure, which have been damaged
due to hepatic fibrosis (15–17). In addition, these studies
demonstrated that ADC values were decreased in fibrotic
and cirrhotic hepatic tissue compared to normal liver
tissue (15–17).
There are many studies showing that DWI was efficient
in the evaluation of the pathologies causing fibrosis along
with benign and malignant lesions of the liver (12,15–17).
These studies encouraged us with the thought that this
imaging technique could be useful in the diagnosis of
liver injuries with underlying experimental extrahepatic
cholestasis and in the follow-up of the continuing
pathological course. We planned this study based on
the hypothesis that, in liver injuries due to extrahepatic
cholestasis, there might be a correlation between DWI
findings and histopathological findings.
2. Materials and methods
2.1. Animals and experimental protocol
Male Sprague Dawley rats, weighing 180–250 g, were
housed in the Experimental Animals Research Laboratory
under standard laboratory conditions (22 ± 1 °C, 12-h
light/dark cycle). All the experimental procedures
described in this study were performed in accordance with
the guidelines of the local ethics committee for animal
studies. Rats were fed with standard rat feed and tap water
ad libitum. All surgical procedures were performed in the
Experimental Animals Research Laboratory.
Twenty-four rats were randomized into four groups
(n = 6), which were designed as follows: control group;
bile duct ligation (BDL) - 3 days group to form mild
fibrosis; BDL - 2 weeks group to form moderate fibrosis;
and BDL - 4 weeks group to form severe fibrosis. The

subjects were anesthetized with 50 mg/kg intramuscular
ketamine hydrochloride and 15 mg/kg intramuscular
xylazine. Laparotomy was performed using a midline
incision. The CBD was found between liver lobes and the
duodenum and it was revealed by doing thin dissections.
An extrahepatic cholestasis model was formed by cutting
the CBD between the knots tied twice from the proximal
of the CBD and once from its distal part using 4/0 silk
sutures. The abdominal wall and skin were closed with
continuous sutures using 3/0 silk suture as separate
layers. At the end of the procedure, groups were placed in
different cages. Hence, in the rats, pathological changes
that could progress up to fibrosis were induced by forming
a choledochus ligation. DWI was performed by repeating
the anesthesia at day 0 in the rats of the control group, at
the end of day 3 in the rats of the BDL - 3 days group, at the
end of day 14 in the rats of the BDL - 2 weeks group, and
at the end of day 28 in the rats of the BDL - 4 weeks group.
In each group, immediately after the completion of the
radiological imaging, the abdominal cavity was opened
and liver tissues were removed for histopathological
examination. Liver tissue samples were placed into Bouin
solution.
2.2. DWI technique
All magnetic resonance imaging was performed at 63.64
MHz (1.5 Tesla Signa HDxt, General Electric, USA).
The system was equipped with 33 mT/m gradient power
with a slew rate of 120. A standard body coil was used
as the radiofrequency transmitter and an eight-channel
standard neurovascular head/neck coil was used as the
receiver. An eight-channel coil was used for application
of parallel imaging technique (ASSET) in order to reduce
susceptibility artifacts. Standard protocol involved a threeplane localizer followed by a coil sensitivity map and a T2weighted axial modified fast spin echo pulse sequence with
repetition time (TR)/echo time (TE), 1840/68 ms; echo
train length (ETL), 16; number of signal averages (NSA),
4; field of view (FOV), 180 × 144 mm2; and matrixes, 192
× 160 with 4 mm slice thickness, which yielded 0.9 × 0.9
× 4.0 pixel size. The DWI sequence used was a modified
spin-echo echo-planar imaging based pulse sequence
with a b-value of 0–100 and 0–500 s/mm2 in two separate
acquisitions but with identical imaging parameters. Each
b-value was acquired with b 0 in order to produce ADC
maps. The diffusion gradients were applied in all three
orthogonal directions. Additional DWI parameters were:
TR/TE, 2000/min; FOV, 180 × 90 mm; matrixes, 64 × 48
with 4 mm slice thickness; and NSA, 8. A parallel imaging
option ASSET with an acceleration factor of two was used.
Measurements were done with the Functool Performance
(volume share 2 - AW4.4) commercial program provided
by General Electric Company on their Advantage
Workstation 4.6. Initially, T2-weighted and diffusion-
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weighted images were placed in a row. A region of interest
(ROI) was selected from proper parenchymal tissue. An
ROI area of 15 mm2 was used for all measurements. All
measurements were done on two consecutive slices that
displayed proper liver parenchyma to avoid partial volume
effect from results. Four ADC values were determined from
both left and right liver lobes. The average was considered
the parenchymal mean ADC value. The same procedure
was applied to b 100 (s/mm2) and b 500 (s/mm2)
2.3. Histopathological examination
The liver tissues were collected and immediately ﬁxed
with 10% neutral buffered formalin and embedded in
parafﬁn. Sections (5 µm) were prepared and then stained
with hematoxylin and eosin dye for photomicroscopic
observations. Liver ﬁbrosis was evaluated by a
semiquantitative method to assess the degree of
histological injury using the following criteria: grade 0,
normal liver (F0); grade 1, few collagen ﬁbrils extended
from the central vein to the portal tract (F1); grade 2,
apparent collagen ﬁbril extension without encompassing
the whole lobule (F2); grade 3, collagen ﬁbrils extended
into and encompassing the whole lobule (F3); grade 4,
diffuse extension of collagen ﬁbrils and formation of
pseudolobule (F4) (18).
2.4. Statistical analysis
All statistical analyses were completed using SPSS 15.0 for
Windows. Statistical analysis of the control and the three
experimental groups was compared using one-way analysis
of variance (ANOVA) and the least significant difference
(LSD) post hoc test. P < 0.05 was considered statistically
significant. All values were expressed as mean ± standard
deviation. Spearman’s rank correlation test was used to
assess the correlation between hepatic ADC and stage of
fibrosis. The diagnostic performance of DWI was assessed
with a receiver operating characteristic (ROC) curve. An
ROC curve is a plot of sensitivity versus (1 – specificity) for
all possible cutoff values. The most commonly used index
of accuracy is the area under the ROC curve (AUC), with
values close to 1.0 indicating high diagnostic accuracy.
3. Results
In our study, when fibrosis scores generated in all groups
were evaluated together, a strong negative correlation
was detected between fibrosis scores and ADC values
measured using b 100 (s/mm2) (Spearman rho = –0.747
and P < 0.01). Similarly, when fibrosis scores generated
in all groups were evaluated together, a marked negative
correlation was detected between fibrosis scores and ADC
values measured using b 500 (s/mm2) (Spearman rho =
–0.743 and P < 0.01).
3.1. DWI findings
DWIs performed at b 100 (s/mm2) and b 500 (s/mm2)
are shown in Figures 1a–1d and 2a–2d. In Figures 1a and
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2a, images of the normal hepatic parenchymal structure
obtained in the control group are shown. In the BDL - 3
days group, both b levels led to mild dilation in the bile
ducts (Figures 1b and 2b). In BDL - 2 weeks (Figures 1c
and 2c) and in BDL - 4 weeks (Figures 1d and 2d), both b
levels led to marked dilation in the bile ducts.
While the lowest ADC values calculated using both b
100 (s/mm2) and b 500 (s/mm2) were obtained in the BDL
- 4 weeks group, the highest ADC value was detected in the
control group and it was significantly higher compared to
the other groups (P < 0.001). At b 100 (s/mm2), the ADC
value calculated in the BDL - 3 days group was substantially
higher than in the BDL - 2 weeks and BDL - 4 weeks
groups, respectively (P < 0.003 and P < 0.001). However,
ADC values were not significantly different between the
BDL - 2 weeks and BDL - 4 weeks groups (P > 0.05).
When b 500 (s/mm2) was used, the ADC value calculated
in the BDL - 3 days group was significantly higher than
in the BDL - 4 weeks group (P < 0.002), whereas it was
not significantly different in the BDL - 2 weeks group (P >
0.05). On the other hand, when b 500 (s/mm2) was used,
the ADC value measured in the BDL - 2 weeks group was
substantially higher compared to the BDL - 4 weeks group
(P < 0.02). ADC values calculated using b 100 (s/mm2) and
b 500 (s/mm2) for the groups are given in the Table.
3.2. Histopathological findings
Histopathological examination of the control liver showed
normal liver tissue. The control rats showed no fibrosis
(Figure 3a). In the BDL - 3 days group, inflammatory cell
infiltration and fibrosis had begun (Figure 3b). In the BDL
- 2 weeks group, ductular proliferation was added to the
fibrotic process (Figure 3c). In the BDL - 4 weeks group,
dense inflammatory cell infiltration, ductular proliferation,
and diffuse fibrosis were noteworthy (Figure 3d).
While fibrosis score was significantly higher in the
BDL - 3 days group than in the control group (P < 0.001),
it was substantially lower in the BDL - 3 days group
compared to the BDL - 2 weeks group (P < 0.001). While
the fibrosis score was markedly higher in the BDL - 2
weeks group compared to the control group (P < 0.0001),
it was substantially lower compared to the BDL - 4 weeks
group (P < 0.001). The fibrosis score obtained in the BDL
- 4 weeks group was markedly higher than in the control
and BDL - 3 days groups (P < 0.0001). The results of the
fibrosis scores for each group are given in the Table.
3.3. Assessment of fibrosis by DWI and fibrosis scores
ROC curves were used to analyze the usefulness of ADC
values for predicting fibrosis stage. For the differentiation
of the absence of fibrosis and mild fibrosis (F0–F1)
from moderate and severe fibrosis (F2–F4), ADC values
obtained using b 100 (s/mm2) had an AUC of 0.868,
sensitivity of 80.00%, and specificity of 92.86%. For the
differentiation of the absence of fibrosis and mild fibrosis
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a

b

c

d

Figure 1. DWI (b 100) of the liver: a) Control group. b) Mild dilatation of the central
bile ducts is seen in BDL - 3 days group. c) Significant dilatation of central bile ducts is
seen in BDL - 2 weeks group. d) BDL - 4 weeks group.
a

b

c

d

Figure 2. DWI (b 500) of the liver; ADC values are lower than those for b 100 (see
Table): a) Control group. b) BDL - 3 days group. c) BDL - 2 weeks group. d) BDL - 4
weeks group.
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a

b

c

d

Figure 3. a) Control group, normal liver tissue. b) From 3 days after BDL, inflammatory
cell infiltration (arrow) and fibrosis (*) were predominant. c) From 2 weeks after BDL,
ductular proliferation (arrow) and fibrosis (*). d) From 4 weeks after BDL, intensive
inflammatory cell infiltration (arrow), ductular proliferation (arrowhead), and diffuse
fibrosis (*). H&E, magnification: a and d, 100×; b and c, 200×.

Table. The apparent diffusion coefficients (ADCs) and fibrosis scores for each group.
Control
ADC (×10–3 mm2/s)
(using b 100 s/mm2)

5.07 ± 0.60a

BDL - 3 days

BDL - 2 weeks

BDL - 4 weeks

3.17 ± 0.65b,c

2.16 ± 0.49

2.04 ± 0.24

ADC (×10–3 mm2/s)
(using b 500 s/mm2)

2.25 ± 0.24a

1.70 ± 0.26d

1.56 ± 0.10e

Fibrosis score

0.00 ± 0.00

1.67 ± 0.81f

2.33 ± 0.81g,c

Values are expressed as mean ± SD; n = 6 for each group.
a
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P < 0.0001 compared with BDL - 3 days, BDL - 2 weeks, and BDL - 4 weeks.

b

P < 0.003 compared with BDL - 2 weeks.

c

P < 0.001 compared with BDL - 4 weeks.

d

P < 0.002 compared with BDL - 4 weeks.

e

P < 0.02 compared with BDL - 4 weeks.

f

P < 0.001 compared with control and BDL - 2 weeks.

g

P < 0.0001 compared to control.

h

P < 0.0001 compared to control and BDL - 3 days.

1.26 ± 0.18
3.00 ± 0.63h
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(F0–F1) from moderate and severe fibrosis (F2–F4), ADC
values obtained using b 500 (s/mm2) had an AUC of 0.875,
sensitivity of 80.00%, and specificity of 100.00% (Figure 4).
4. Discussion
Cholestasis may result from bile duct obstruction and
accumulation of the bile in the liver due to several
pathologies, such as obstructive, inflammatory, and genetic
conditions. Increased pressure in the bile ducts leads to
the accumulation of toxic substances and to macroscopic
and microscopic changes in the liver, preventing bile flow.
When obstruction persists, fibrosis and consequently
biliary cirrhosis develop around the bile ducts (19).
The rat model of hepatic fibrosis induced by CBD
ligation is an interesting fibrosis model used in the most
recent scientific studies because it forms rapidly and
complies with primary or secondary biliary cirrhosis in
humans. When CBD ligation is administered to rats, it
forms extracellular matrix proteins, especially collagen, in
the liver, and it is a suitable model for the development
of secondary hepatic fibrosis in rats (20). In our study, we
used this model in order to form fibrosis in the liver.
It is difficult to evaluate hepatic fibrosis and
inflammation using conventional MRI (21). Several
studies demonstrated that ADC values were lower in
the cirrhotic liver compared to normal livers (22–26).
1.0

Sensitivity

0.8

0.6

Source of the
Curve
b 100
b 500
Reference Line

0.4

0.2

0.0

0.0

0.2

0.4
0.6
1 - Specificity

0.8

1.0

Figure 4. ROC curve with ADC for differentiating absence of
fibrosis (F0) and mild fibrosis (F1) from moderate to severe
fibrosis (F2–F4). For b 100 (s/mm2) the AUC is 0.868 with a
sensitivity of 80.00% and specificity of 92.86%. ADC criterion
value is ≤2.90 × 10–3 mm2/s. For b 500 (s/mm2) the AUC is 0.875
with a sensitivity of 80.00% and specificity of 100.00%. The ADC
criterion value ≤1.82 × 10–3 mm2/s.

In a study performed by Koinuma et al. (15) on a large
series of subjects using a low b-value (128 s/mm2), it
was demonstrated that there was an important negative
correlation between ADC and fibrosis score, but there
was no correlation between ADC values and the degree
of inflammation. Sandrasegaran et al. (Spearman rho =
–0.36) and Taouli et al. (Spearman rho = –0.45) reported
a moderately negative correlation between ADC values
and fibrosis stages (27,28). In our study, when evaluated
along with the grades of fibrosis observed in all groups,
the finding of a strong negative correlation between ADC
values obtained with both b 100 (s/mm2) and b 500 (s/
mm2) showed consistency with the results of those studies.
On the other hand, Boulanger et al. could not detect a
significant correlation between ADC values and fibrosis
and inflammation grades (29). However, when evaluating
the results obtained by Boulanger et al., it should be
considered that this study was conducted with a small
sample size (18 patients with hepatitis C and 10 controls),
which could be a potential limiting factor for the power of
the study.
In a clinical study performed by Lewin et al. (54 patients
with chronic hepatitis C and 20 healthy volunteers), the
efficacies of serum markers of fibrosis and sonographic
elastography technique were compared using DWI (using
b-values of 0, 200, 400, and 800 s/mm2) (30). In this
study, it was reported that ADC could predict moderate
and severe fibrosis well. In addition, it was demonstrated
that ADC values were substantially lower in patients
with moderate and severe fibrosis (F2–F4) compared to
patients without fibrosis or with mild fibrosis (F0–F1)
and to healthy volunteers. Similarly, in our study, ADC
values were significantly lower in the BDL - 2 weeks
(moderate fibrosis) and BDL - 4 weeks (severe fibrosis)
groups compared to the control and BDL - 3 (mild
fibrosis) groups. Additionally, Lewin et al. reported that
the sensitivity and specificity of the ADC values were both
87% in the differentiation of patients with F3–F4 fibrosis
from those with F0–F2 fibrosis. Girometti et al. reported
that ADC values had sensitivity and specificity of 92% and
100%, respectively, and were significantly lower in cirrhotic
patients compared to healthy volunteers (31). In another
study, it was reported that ADC values were important in
the prediction of F2 or greater fibrosis and F3 or greater
fibrosis, and their sensitivities were 83.3% and 88.9% and
their specificities were 83.3% and 80.0%, respectively (17).
Sandrasegaran et al. detected that, in the differentiation of
F0–F1 fibrosis and F2–F4 fibrosis in patients with chronic
viral hepatitis, ADC values had sensitivity and specificity
of 72.6% and 59.3%, respectively (27). However, in our
study, we detected that ADC values had higher sensitivity
and specificity rates in the differentiation of the same
fibrosis stages.

691

AYVAZ et al. / Turk J Med Sci
ADC measurement depends on many factors (32,33).
Among these factors, b-level is very important for
calculating ADC. ADC measurements performed using
images obtained with higher b-values are more sensitive
and the ADC values obtained are generally lower than
the values obtained using b-values of less than 500 s/
mm2. However, compared to b-values above 800 s/mm2,
ADC values calculated using an intermediate b-value of
400 s/mm2 may be more advantageous in the evaluation
of hepatic fibrosis (31). It is known that hepatic perfusion
is substantially decreased in cirrhotic patients compared
to healthy people (34). Annet et al. detected a negative
correlation between the decrease of ADC values and
increased fibrosis scores in rats in which hepatic fibrosis
was formed and they reported that, after the sacrifice of
the rats, no significant difference was found between
ADC values (35). As a result, it was reported that, in
the evaluation of hepatic fibrosis using DWI, a decrease
of liver perfusion had a greater effect on ADC values
compared to the limitation of the water diffusion in the
hepatic fibrosis. In another clinical study, a decrease of
ADC values was demonstrated with decreasing perfusion
in cirrhotic patients (16). Lower b-values are more
sensitive to the effects of decreased perfusion and may
be more efficient in differentiating hepatic fibrosis stages
(27). In our study, the ADC values in the control group
were consistent with the values of previous reports (16,35),
and ADC values obtained with a low b-value (b 100 s/
mm2) were significantly higher in early-stage mild fibrosis
(BDL - 3 days) than in both moderate (BDL - 2 weeks)
and severe (BDL - 4 weeks) fibroses; however, ADC values

were not significantly different between the BDL - 2 weeks
and BDL - 4 weeks groups. On the other hand, ADC values
obtained with a higher b-value (b 500 m/mm2) in the mild
fibrosis (BDL - 3 days) were only significantly different
from the values for severe (BDL - 4 weeks) fibrosis. These
results suggested that low b-values may be more efficient
in differentiating between early fibrosis and other fibrosis
stages (moderate and severe). However, while ADC values
obtained with a low b-value (b 100 s/mm2) did not show a
significant difference between moderate (BDL - 2 weeks)
and severe (BDL - 4 weeks) fibroses, ADC values calculated
using a high b-value (b 500 s/mm2) showed a significant
difference. Our results suggest that high b-values may be
more efficient in the differentiation of moderate and severe
fibroses.
In conclusion, we observed a negative correlation
between ADC values and the grade of the hepatic fibrosis
that developed with underlying experimental BDL, in
parallel with our baseline hypothesis. In addition, we
found a significant difference between fibrosis scores and
ADC values. In light of these results, we think that DWI
may be useful in the diagnosis of several diseases that
cause extrahepatic cholestasis-related hepatic fibrosis,
in the staging of fibrosis, and in the evaluation of the
therapeutic response. We think that, due to likely minor
or major biopsy complications, the noninvasive nature
of DWI makes it a viable alternative to liver biopsy. We
suggest that clinical studies conducted on large series of
patients who developed extrahepatic cholestasis due to
several diseases would be useful.
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